PARLIAMENTARY WRITTEN QUESTION
(6 January 2025)

Diagnostic tests for chronic urinary tract infections (UTIs), such as urinalysis and urine culture, are widely available across all pathology networks in England. Ensuring accurate diagnostic testing not only aids more effective identification of infection but can also reduce unnecessary prescribing and overprescribing of broad-spectrum antimicrobials and directly benefit patients who get the right treatment sooner.

General practitioners can request testing for chronic UTIs via several pathways, including at point-of-care, via community diagnostic centres, or via laboratories. Laboratories across England adhere to stringent quality standards for diagnostic tests, including the UK Accreditation Standard ISO 15189, and implement robust internal and external quality assurance schemes. Together, these measures ensure the accuracy and reliability of diagnostic testing.

The development of new products to diagnose infections more accurately is essential to ensure we can continue to treat infections and protect public health. NHS England is also supporting research into newer, more accurate point-of-care tests for UTIs, such as via the Toucan study. More information on the study is available at the following link:

https://www.phctrials.ox.ac.uk/recruiting-trials/toucan-platform-for-uti-diagnostic-evaluation